GENEVA, Oct. 9 -- RECORNA (GUANGZHOU) BIOTECHNOLOGY CO., LTD filed a patent application (CN2026/088027) for “ADAR GUIDE RNA FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY”. With publication no. WO/2026/208948, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....